According to Santen Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 0.17%. At the end of 2022 the company had an Operating Margin of 13.83%.
Year | Operating Margin | Change |
---|---|---|
2022 | 13.83% | 148.25% |
2021 | 5.57% | -60.97% |
2020 | 14.28% | -27.37% |
2019 | 19.66% | 11.38% |
2018 | 17.65% | 5.23% |
2017 | 16.77% | -59.55% |
2016 | 41.46% | 85.63% |
2015 | 22.33% | 23.43% |
2014 | 18.09% | -15.84% |
2013 | 21.50% | -11.56% |
2012 | 24.31% | -13.41% |
2011 | 28.07% | 8.33% |
2010 | 25.92% | 65.76% |
2009 | 15.64% | -21.44% |
2008 | 19.90% | -5.35% |
2007 | 21.03% | 1.25% |
2006 | 20.77% | 3.39% |
2005 | 20.09% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.